Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-16-061621)

Filing Details

Accession Number:: 0001140361-16-061621
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-04-20 11:14:32
Reporting Period:: 2016-04-18

Filing Date:: 2016-04-20
Accepted Time:: 2016-04-20 11:14:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380187	Daniel Abdun-Nabi	400 Professional Dr, Suite 400 Gaithersburg MD 20879	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-04-18	2,749	$40.17	194,319	No	4	S	Direct
Common Stock	Disposition	2016-04-18	3,580	$40.17	190,739	No	4	S	Direct
Common Stock	Disposition	2016-04-18	2,373	$40.17	188,366	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi.
Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.03 to $40.32, inclusive.